NCT06445959
- Conditions
- Mutant IDH1 Inhibitor Olutasidenib
- Locations
-
- The University of Kansas Medical Center Westwood, Kansas, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Roswell Park Buffalo, New York, United States
- MD Anderson Cancer Center Houston, Texas, United States